Fontana E, Boucher J, Marti L, Lizcano J M, Testar X, Zorzano A, Carpéné C
Institut National de la Santé et de la Recherche Médicale, Unité 317, Institut Fédératif de Recherches 31, CHU Rangueil, 31403 Toulouse, France.
Biochem J. 2001 Jun 15;356(Pt 3):769-77. doi: 10.1042/0264-6021:3560769.
We have previously reported that substrates of monoamine oxidase (MAO) and semicarbazide-sensitive amine oxidase (SSAO) exert short-term insulin-like effects in rat adipocytes, such as stimulation of glucose transport. In the present work, we studied whether these substrates could also mimic long-term actions of insulin. Adipose differentiation of 3T3 F442A cells, which is highly insulin-dependent, served as a model to test the effects of sustained administration of amine oxidase substrates. Daily treatment of confluent cells with 0.75 mM tyramine (a substrate of MAO and SSAO) or benzylamine (a substrate of SSAO) over 1 week caused the acquisition of typical adipocyte morphology. The stimulation of protein synthesis and triacylglycerol accumulation caused by tyramine or benzylamine reached one half of that promoted by insulin. This effect was insensitive to pargyline (an MAO inhibitor), but was inhibited by semicarbazide (an SSAO inhibitor) and by N-acetylcysteine (an antioxidant agent), suggesting the involvement of the H(2)O(2) generated during SSAO-dependent amine oxidation. Chronic administration of amine oxidase substrates also induced the emergence of adipose conversion markers, such as aP2, glycerol-3-phosphate dehydrogenase, the glucose transporter GLUT4, and SSAO itself. Moreover, cells treated with amines acquired the same insulin sensitivity regarding glucose transport as adipocytes classically differentiated with insulin. In all, most of the adipogenic effects of amines were additive to insulin. Our data reveal that amine oxidase substrates partially mimic the adipogenic effect of insulin in cultured preadipocytes. Furthermore, they suggest that SSAO not only represents a novel late marker of adipogenesis, but could also be directly involved in the triggering of terminal adipocyte differentiation.
我们之前曾报道,单胺氧化酶(MAO)和氨基脲敏感胺氧化酶(SSAO)的底物在大鼠脂肪细胞中发挥短期胰岛素样作用,如刺激葡萄糖转运。在本研究中,我们探究了这些底物是否也能模拟胰岛素的长期作用。高度依赖胰岛素的3T3 F442A细胞的脂肪分化用作模型,以测试持续给予胺氧化酶底物的效果。在1周时间里,用0.75 mM酪胺(MAO和SSAO的一种底物)或苄胺(SSAO的一种底物)每日处理汇合细胞,导致细胞获得典型的脂肪细胞形态。酪胺或苄胺引起的蛋白质合成和三酰甘油积累的刺激作用达到胰岛素促进作用的一半。这种作用对帕吉林(一种MAO抑制剂)不敏感,但被氨基脲(一种SSAO抑制剂)和N - 乙酰半胱氨酸(一种抗氧化剂)抑制,提示SSAO依赖性胺氧化过程中产生的H₂O₂参与其中。长期给予胺氧化酶底物还诱导了脂肪转化标志物的出现,如aP2、甘油 - 3 - 磷酸脱氢酶、葡萄糖转运蛋白GLUT4以及SSAO自身。此外,用胺处理的细胞在葡萄糖转运方面获得了与经典用胰岛素分化的脂肪细胞相同的胰岛素敏感性。总之,胺的大多数脂肪生成作用与胰岛素的作用具有相加性。我们的数据表明,胺氧化酶底物在培养的前脂肪细胞中部分模拟了胰岛素的脂肪生成作用。此外,它们提示SSAO不仅是脂肪生成的一种新的晚期标志物,还可能直接参与终末脂肪细胞分化的触发。